You have 0 free articles left this month.
Advertisement
Big Law

ANSTO extends partnership with ITM

The Australian Nuclear Science and Technology Organisation has secured a long-term IP and technology license agreement with a Germany-based company.

March 23, 2022 • By Naomi Neilson
Share this article on:
Facebook X LinkedIn
ANSTO extends partnership with ITM
expand image

Firm: Maddocks (ANSTO)

 
 

This content is available exclusively to Lawyers Weekly premium members.
Deal: Maddocks has advised the Australian Nuclear Science and Technology Organisation (ANSTO) on a new long-term IP and technology license agreement with leading German radiopharmaceutical biotech company ITM Isotope Technologies Munich SE.

Value: N/A

Area: IP

Key players: The team was led by IP and life sciences partner Ben Miller, who was assisted by lawyer Sophie Vo and the firms’ IP and pharma regulatory team.

Deal significance: The continuation of ANSTO’s longstanding partnership with ITM is significant as it allows local manufacturing to continue to support the growing demands of patients in the Australia-New Zealand region.

Naomi Neilson
Naomi Neilson
Naomi Neilson is a senior journalist with a focus on court reporting for Lawyers Weekly, as well as other titles under the Momentum Media umbrella. She regularly writes about matters before the Federal Court of Australia, the Supreme Courts, the Civil and Administrative Tribunals, and the Fair Work Commission. Naomi has also published investigative pieces about the legal profession, including sexual harassment and bullying, wage disputes, and staff exoduses. You can email Naomi at: naomi.neilson@momentummedia.com.au.
Tags